Skip to content
CancerIndex

Publication

Pediatric low-grade gliomas can be molecularly stratified for risk.

Authors not recorded

Acta Neuropathol2018PMID 29948154stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (14)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 14

Curated evidence

Evidence citing this paper (7)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
29948154
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–7 of 7 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
ATRX Underexpression1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Poor Outcome4accepted
EID7190

Loss of ATRX was identified in 12 of 247 patients with PLGGs using immunohistochemistry. Survival analysis showed that ATRX loss was associated with adverse overall survival (p<0.0001) and progression… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
BRAF V600E1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Poor Outcome4accepted
EID7191

Using Sanger sequencing, BRAFV600E mutations were identified in 21 of 285 patients with PLGGs (7.4%). This mutation was enriched in hemispheric tumors (p<0.007) and was associated with shorter progres… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
CDKN2A Deletion1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Poor Outcome4accepted
EID7192

CDKN2A deletion was identified in 24 of 273 patients with PLGGs using FISH analysis. An association between this alteration and BRAFV600E was detected (p=0.0001). Hemispheric tumors with CDKN2A deleti… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
H3-3A MUTATION1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Poor Outcome4accepted
EID7189

Using Sanger sequencing, H3F3A mutations in patients with pediatric low-grade gliomas (PLGGs) were identified (K27M: 13/280; G34R: 5/280). Kaplan-Meier survival analysis showed that H3F3A mutations we… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
BRAF Fusion1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Better Outcome4accepted
EID7193

KIAA1549-BRAF fusion was identified in 87 of 272 patients with PLGGs using Fluorescence In situ hybridization (FISH) analysis. This mutation was strongly associated with a greater progression-free sur… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
MYB AMPLIFICATION1
(prognostic)Childhood Low Grade GliomaPrognosticBSupports Better Outcome4accepted
EID7194

MYB amplification was detected in 28 of 263 patients with PLGGs using Fluorescence In situ hybridization (FISH) analysis. The amplification of MYB was strongly associated with greater progression-free… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic
TERT Promoter Mutation1
(prognostic)Childhood Low Grade GliomaPrognosticCSupports Poor Outcome4accepted
EID7188

The aim of this Chinese study was to identify prognostic biomarkers for pediatric low-grade gliomas (PLGG). Approximately 300 patients were included. Using Sanger sequencing, mutations at TERT promote… (full text at CIViC)

PMID 29948154 · Yang et al., 2018 · Open in CIViC

civic